137 related articles for article (PubMed ID: 8276715)
1. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study.
Hiwatashi N; Morimoto T; Fukao A; Sato H; Sugahara N; Hisamichi S; Toyota T
Jpn J Cancer Res; 1993 Nov; 84(11):1110-2. PubMed ID: 8276715
[TBL] [Abstract][Full Text] [Related]
2. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study.
Saito H; Soma Y; Koeda J; Wada T; Kawaguchi H; Sobue T; Aisawa T; Yoshida Y
Int J Cancer; 1995 May; 61(4):465-9. PubMed ID: 7759151
[TBL] [Abstract][Full Text] [Related]
3. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test.
Saito H; Soma Y; Nakajima M; Koeda J; Kawaguchi H; Kakizaki R; Chiba R; Aisawa T; Munakata A
Oncol Rep; 2000; 7(4):815-9. PubMed ID: 10854550
[TBL] [Abstract][Full Text] [Related]
4. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
[TBL] [Abstract][Full Text] [Related]
6. The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer.
Doubeni CA; Corley DA; Jensen CD; Schottinger JE; Lee JK; Ghai NR; Levin TR; Zhao WK; Saia CA; Wainwright JV; Mehta SJ; Selby K; Doria-Rose VP; Zauber AG; Fletcher RH; Weiss NS
J Med Screen; 2021 Jun; 28(2):140-147. PubMed ID: 32438892
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
Nakama H; Kamijo N
Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
10. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
11. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
Mandel JS; Bond JH; Church TR; Snover DC; Bradley GM; Schuman LM; Ederer F
N Engl J Med; 1993 May; 328(19):1365-71. PubMed ID: 8474513
[TBL] [Abstract][Full Text] [Related]
12. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
13. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy.
Zappa M; Castiglione G; Grazzini G; Falini P; Giorgi D; Paci E; Ciatto S
Int J Cancer; 1997 Oct; 73(2):208-10. PubMed ID: 9335444
[TBL] [Abstract][Full Text] [Related]
14. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study.
Nakama H; Kamijo N; Abdul Fattah AS; Zhang B
J Med Screen; 1996; 3(2):63-5. PubMed ID: 8849761
[TBL] [Abstract][Full Text] [Related]
15. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of effectiveness of mass screening for colorectal cancer.
Fujita M; Sugiyama R; Kumanishi Y; Ota J; Horino T; Nakano Y; Taguchi T
World J Surg; 1990; 14(5):648-52; discussion 652-3. PubMed ID: 2238667
[TBL] [Abstract][Full Text] [Related]
17. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
Wahrendorf J; Robra BP; Wiebelt H; Oberhausen R; Weiland M; Dhom G
Eur J Cancer Prev; 1993 May; 2(3):221-7. PubMed ID: 8490540
[TBL] [Abstract][Full Text] [Related]
19. [Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].
Huang YQ; Zhang MW; Shen YZ; Ma HQ; Cai SR; Zhang SZ; Zheng S
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):747-51. PubMed ID: 24246083
[TBL] [Abstract][Full Text] [Related]
20. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study.
Selby JV; Friedman GD; Quesenberry CP; Weiss NS
Ann Intern Med; 1993 Jan; 118(1):1-6. PubMed ID: 8416152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
